Women in an online-first treatment program saw Total Cholesterol fall by an average of 0.77 mmol/L. The Nature Medicine report examined GLP-1 Medications, medicines that help lower appetite, in women. Care was delivered through an online-first program. The reported blood fat results came from women with measurements at two time points. That allowed researchers to compare changes within the same people. Average Total Cholesterol fell by 0.77 mmol/L. LDL Cholesterol, often called bad cholesterol, fell by 0.61 mmol/L. Triglycerides, another type of blood fat, fell by 0.47 mmol/L. These are changes in blood levels, not percentage drops. There was also a less straightforward result. HDL Cholesterol, often called good cholesterol, fell by 0.19 mmol/L. Not every lower number means the same thing. That makes the full blood test more useful than one headline result. Larger drops in Weight were linked to larger cholesterol drops. Each 10 kg lost was linked to 0.23 mmol/L lower Total Cholesterol and 0.14 mmol/L lower LDL Cholesterol. This link does not prove that the medicines alone caused those changes. The supplied excerpt also leaves out the group size and time between tests. For BioSocial members, the useful takeaway goes beyond the scale. Tracking bloodwork alongside treatment dates can show how your own numbers move together. Comparing notes with others is more meaningful when test timing and units match. These averages offer context, not a target everyone should expect to reach. What changes have you seen in your cholesterol results during treatment, and over what time period?